Coronavirus vaccine update: Oxford-AstraZeneca vaccine candidate enters phase 3 human trials in the US
The US trials are likely to include around 30,000 participants. Coronavirus vaccine: The vaccine candidate developed by the Oxford University and pharmaceutical company AstraZeneca has entered the phase 3 human clinical trials in the US. The phase 3 trials for the candidate are already underway in numerous countries like India, South Africa, England, and Brazil, … Read more
